Drug Metabolism, Poor, Cyp2d6-related

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Drug Metabolism, Poor, Cyp2d6-related

CYP2D6

View recommended genes panels

Clinical Features

Phenotypes and symptoms related to Drug Metabolism, Poor, Cyp2d6-related

Neoplasm
Hypertension
Abnormality of metabolism/homeostasis
Depressivity
Hypotension
Schizophrenia

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Drug Metabolism, Poor, Cyp2d6-related Recommended genes panels

Panel Name, Specifity and genes Tested/covered
CYP2D6 Genotyping. By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States). CYP2D6 Specificity 100 % Genes 100 %
Psychiatry Pharmacogenetics Expanded Panel. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). CYP2C19, CYP2D6 Specificity 50 % Genes 100 %
Cytochrome P450 Genotype Panel. By ARUP Laboratories, Molecular Genetics and Genomics (United States). CYP2C19, CYP2C9, CYP2D6 Specificity 34 % Genes 100 %
Cytochrome P450 (6 alleles of CYP2D6, CYP2C9, CYP2C19 and CYP3A4). By CGC Genetics (Portugal). CYP2C19, CYP2C9, CYP2D6, CYP3A4 Specificity 25 % Genes 100 %
Cytochrome P450 (13 alleles). By CGC Genetics (Portugal). CYP2C19, CYP2C9, CYP2D6, CYP3A4 Specificity 25 % Genes 100 %
Antidepressants and antipsychotics pharmacogenetics. By CGC Genetics (Portugal). CYP2C19, CYP2D6 Specificity 50 % Genes 100 %
Pharmacogenetic panel for cardiology. By CGC Genetics (Portugal). VKORC1, CYP2C19, CYP2C9, CYP2D6 Specificity 25 % Genes 100 %
Tamoxifen pharmacogenetics. By CGC Genetics (Portugal). CYP2D6 Specificity 100 % Genes 100 %

You can get up to 72 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

MESH OMIM Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like BRUNNER SYNDROME; BRNRS LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB PERLMAN SYNDROME; PRLMNS KANZAKI DISEASE FACTOR XI DEFICIENCY MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7